NetraMark Enhances Board with Pharma Expert
Company Announcements

NetraMark Enhances Board with Pharma Expert

Netramark Holdings Inc (TSE:AIAI) has released an update.

NetraMark Holdings Inc. has bolstered its advisory board with the appointment of pharmaceutical industry veteran Jeff Huntsman, bringing over 30 years of expertise to enhance the company’s AI-driven solutions in precision medicine. Huntsman’s background in commercial and operational leadership is expected to significantly contribute to NetraMark’s growth and commercialization strategies. NetraMark specializes in AI and Machine Learning solutions tailored to the pharmaceutical industry, aiming to optimize clinical trials and market access solutions.

For further insights into TSE:AIAI stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskNetraMark Appoints Oncology Expert P.J. Haley to Board
TipRanks Canadian Auto-Generated NewsdeskNetraMark Unveils New Suite to Revolutionize Clinical Trials
TipRanks Canadian Auto-Generated NewsdeskNetraMark’s Q3 Success with AI Clinical Trial Analytics
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App